CBD, Events, Investment, News

CBD’s potential is tempered by challenges facing the sector

Boaz Wachtel, President of Creso PharmaCannabis veteran Boaz Wachtel, Creso Pharma, will address the Summit
Share this:
  • 109
  •  
  •  
  •  
  •  

As the demand for CBD explodes worldwide, stakeholders must tackle urgent, critical challenges to maximize the sector’s potential. 

From the USA, where a full-fledged CBD market is rapidly emerging, to South America, Europe, Africa and Asia, governments are putting the pieces in place to establish CBD value chains. 

Lack of proper laws, regulatory and jurisdictional clarity are but a few of the problems facing the sector. At the same time the market needs more research, product and industry standards, technology and strong management. Perhaps more importantly, in these formative times, there’s a desperate need for self-policing, and more and more transparency. 

Opportunities & innovation

Meanwhile, opportunities and innovation expand with CBD’s presence in an ever growing number of products and applications.

Leading global stakeholders will analyze these challenges and opportunities during The Future of Medical Hemp Summit hosted by HempToday Aug. 23-24, 2019. The Summit is limited to 25 participants; four accreditations remain available. 

The Summit will look at the current status of the CBD sector and the many opportunities that exist in medical hemp and health products. The basics of cannabinoid extraction, interesting sub-sectors, products and supporting industries will be explored along with the sector’s wide range of specialized services – research and product development; marketing and communications, and technology and machinery.

The Future of Medical Hemp, in its second year, is jointly organized by HempToday, Czech-based Hempoint and the European Industrial Hemp Association. The main sponsor for the event is leading European CBD brand CannabiGold, whose Sales Director, Jacek Kramarz is among the experts who also will address the Summit.

Speaker panel is complete

Cannabis industry veteran Boaz Wachtel, Chairman & co-founder, CresoPharma, a nutraceuticals company traded on the Australian Securities Exchange (ASX), has also confirmed as a speaker. He was co-founder and former managing director of MMJ Phytotech, Australia’s first publicly traded medical cannabis company. He is also co-founder and inventor at rootssat.com, the developer of root zone heating and cooling technology, and co-founder of the International Medical Cannabis Patient Coalition (IMCPC).

Other newly added presenters are Kenneth Holk, DeHolk AB, Sweden; and Paulius Jarusevicius, Bene Facitis, Poland.

Other leading speakers

Previously announced speakers scheduled to appear at the gathering are Steph Sherer, Director of Innovations at Prague-based ICCI which is dedicated to the standardization of industrial hemp production for CBD and other compounds that address human health;  Scott Reese, CEO at Colorado, USA-based, C-Beyond-Health; Boris Banas, CSO at CBDepot, Czech Republic; Muhammed Qayyum, Medics Laboratories Pvt. Ltd., Pakistan; Joscha Krauss, CEO, MH medical hemp GmbH, Germany; Hana Gabrielova, CEO, Hempoint, Czech Republic; and Lorenza Romanese, Managing Director of the European Industrial Hemp Association; 

The all-inclusive fee (€1,299) includes the following:

  • 1 accreditation
  • an opening reception on the evening of Thursday, Aug. 22
  • transportation to and from airports or train stations
  • local transportation
  • hotel room for 3 nights
  • all food and drinks
  • a deluxe hemp gift pack
  • post event summary info packet


Share this:
  • 109
  •  
  •  
  •  
  •  

Get Hemp Industry Updates

* indicates required

Do you want event updates?